jueves, 18 de diciembre de 2014

EuroMeeting 2015 | Patient Advocate Fellowship

EuroMeeting 2015 | Patient Advocate Fellowship

Get involved with hands raised

GET INVOLVED
Information of interest for patients and their representatives
Don’t miss the 10 January deadline to apply for the 2015 DIA EuroMeeting Patient Fellowship Programme, which this time includes a theme on rare diseases
DIA

Patient Advocate Fellowship

The DIA Patient Advocate Fellowship Programme is designed to do the following:
  • Develop, strengthen, and support patient collaborations with policy makers, industry representatives, public health authorities, academia, and other healthcare stakeholders.
  • Improve alliances between patient groups and other healthcare stakeholders
  • Increase knowledge and understanding of issues central to the promotion of patient-centred healthcare, biomedical research, and drug development
  • Provide a forum for sharing best practices, stimulating cooperation, and facilitating a two-way dialogue across the entire global healthcare community.
  • Enhance the capacity of patient advocates to respond to changes in drug development and health care delivery
  • Integrate the patient voice by attending EuroMeeting program offerings, roundtable discussions, and networking events
Who should apply?
  • Applicant should be affiliated with a patient organisation
  • Demonstrated track record of education and/or advocacy activities
  • Patient engagement in or be familiar with activities related to clinical trials, drug development, HTA, regulatory affairs
  • The business language of the conference is English. Patient Fellows must be able to understand scientific content in English and network with other attendees with ease
The deadline for applications is: 10 January 2015Applicants will be notified of acceptance by 13 February 2015

pdf 
More Information and Application Form

- See more at: http://www.diahome.org/en-GB/Flagship-Meetings/EuroMeeting2015/Meeting-Program/Patient-Fellowship.aspx#sthash.wE5rvKNZ.dpuf

No hay comentarios:

Publicar un comentario